BR0012696A - Composição oftálmica - Google Patents
Composição oftálmicaInfo
- Publication number
- BR0012696A BR0012696A BR0012696-9A BR0012696A BR0012696A BR 0012696 A BR0012696 A BR 0012696A BR 0012696 A BR0012696 A BR 0012696A BR 0012696 A BR0012696 A BR 0012696A
- Authority
- BR
- Brazil
- Prior art keywords
- ophthalmic composition
- composition
- ophthal
- active agent
- pharmaceutically active
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Patente de Invenção: "COMPOSIçãO OFTáLMICA". A presente invenção refere-se a uma composição oftálmica contendo cetotifeno como um agente farmaceuticamente ativo.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0017528A BRPI0017528B8 (pt) | 1999-07-23 | 2000-07-21 | uso de uma composição contendo sal de cetotifeno |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99114508 | 1999-07-23 | ||
PCT/EP2000/007030 WO2001007049A2 (en) | 1999-07-23 | 2000-07-21 | Ophthalmic composition comprising ketotifen |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0012696A true BR0012696A (pt) | 2002-04-09 |
Family
ID=8238654
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0012696-9A BR0012696A (pt) | 1999-07-23 | 2000-07-21 | Composição oftálmica |
BRPI0017528A BRPI0017528B8 (pt) | 1999-07-23 | 2000-07-21 | uso de uma composição contendo sal de cetotifeno |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0017528A BRPI0017528B8 (pt) | 1999-07-23 | 2000-07-21 | uso de uma composição contendo sal de cetotifeno |
Country Status (20)
Country | Link |
---|---|
US (2) | US6777429B1 (pt) |
EP (1) | EP1198223A2 (pt) |
JP (1) | JP2003505419A (pt) |
KR (1) | KR20020012261A (pt) |
CN (1) | CN1358086A (pt) |
BR (2) | BR0012696A (pt) |
CA (1) | CA2377024A1 (pt) |
CZ (1) | CZ300614B6 (pt) |
EE (1) | EE05439B1 (pt) |
HK (1) | HK1046631A1 (pt) |
HU (1) | HU230738B1 (pt) |
IL (1) | IL146973A0 (pt) |
MX (1) | MXPA02000849A (pt) |
NO (1) | NO331228B1 (pt) |
NZ (1) | NZ516108A (pt) |
PL (1) | PL202496B1 (pt) |
RU (1) | RU2248789C2 (pt) |
UA (1) | UA74788C2 (pt) |
WO (1) | WO2001007049A2 (pt) |
ZA (1) | ZA200200425B (pt) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR034372A1 (es) * | 2001-06-08 | 2004-02-18 | Novartis Ag | Composiciones farmaceuticas |
WO2002100436A2 (en) * | 2001-06-08 | 2002-12-19 | Novartis Ag | Ophthalmic once-a-day composition |
AR034371A1 (es) * | 2001-06-08 | 2004-02-18 | Novartis Ag | Composiciones farmaceuticas |
US20060036220A1 (en) * | 2003-01-22 | 2006-02-16 | Kohji Kawahara | Percutaneous absorption preparation for treating ophthalmic disease, use thereof and method for migration of ophthalmic remedy into topical tissue in eye |
US20060089384A1 (en) * | 2004-10-25 | 2006-04-27 | Minno George E | Ophthalmic compositions and methods of using the same |
US20070208058A1 (en) * | 2004-10-25 | 2007-09-06 | Bryant Roy W | Stable Pharmaceutical Compositions and Methods of Making and Using Same |
EP1845983B1 (en) * | 2004-10-25 | 2010-04-07 | Bausch & Lomb Incorporated | Ophthalmic compositions and methods of using the same |
US20070048389A1 (en) * | 2005-08-26 | 2007-03-01 | Fu-Pao Tsao | Stabilized and preserved ketotifen ophthalmic compositions |
US20070077302A1 (en) * | 2005-09-30 | 2007-04-05 | Azaam Alli | Methods for stabilizing ophthalmic compositions |
LT2944306T (lt) | 2006-06-16 | 2021-02-25 | Regeneron Pharmaceuticals, Inc. | Vfgf antagonisto kompozicijos, tinkamos įvedimui intravitrealiniu būdu |
US8445437B2 (en) * | 2006-07-27 | 2013-05-21 | The Brigham And Women's Hospital, Inc. | Treatment and prevention of cardiovascular disease using mast cell stabilizers |
ES2624960T3 (es) | 2006-09-29 | 2017-07-18 | Johnson & Johnson Vision Care, Inc. | Método de fabricación de dispositivos oftálmicos usados en el tratamiento de alergias oculares |
WO2008153761A1 (en) * | 2007-05-23 | 2008-12-18 | Mastcell Pharmaceuticals, Inc. | Methods |
US8445435B2 (en) * | 2007-09-28 | 2013-05-21 | The Brigham And Women's Hospital, Inc. | Mast cell stabilizers in the treatment of obesity |
WO2009142772A2 (en) * | 2008-05-23 | 2009-11-26 | Mastcell Pharmaceuticals, Inc. | Methods and treatment for allergies and inflammation associated with gastrointestinal diseases |
US20100240624A1 (en) * | 2009-03-17 | 2010-09-23 | Aciex Therapeutics, Inc. | Ophthalmic Formulations of Ketotifen and Methods of Use |
RU2549472C1 (ru) * | 2013-12-26 | 2015-04-27 | Илья Александрович Марков | Фармацевтическая композиция в форме капель для профилактики и лечения аллергических заболеваний глаз |
FI3384049T3 (fi) | 2015-12-03 | 2023-09-25 | Regeneron Pharma | Menetelmiä geenimuunnosten liittämiseksi kliiniseen tulokseen potilailla, jotka kärsivät silmänpohjan ikärappeumasta ja joita on hoidettu anti-VEGF:llä |
CN111450051B (zh) * | 2020-04-21 | 2022-03-18 | 武汉贝参药业股份有限公司 | 一种富马酸酮替芬口服溶液的制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62277323A (ja) | 1986-02-19 | 1987-12-02 | Sankyo Co Ltd | フマル酸ケトチフエン含有点眼液の製法 |
JPH07324034A (ja) * | 1994-05-30 | 1995-12-12 | Toa Yakuhin Kk | フマル酸ケトチフェン含有の点眼剤 |
JPH11189533A (ja) * | 1997-12-25 | 1999-07-13 | Taisho Pharmaceut Co Ltd | 点眼薬 |
EP0938896A1 (en) | 1998-01-15 | 1999-09-01 | Novartis AG | Autoclavable pharmaceutical compositions containing a chelating agent |
-
2000
- 2000-07-19 US US09/619,349 patent/US6777429B1/en not_active Expired - Lifetime
- 2000-07-21 MX MXPA02000849A patent/MXPA02000849A/es active IP Right Grant
- 2000-07-21 RU RU2002103315/15A patent/RU2248789C2/ru active
- 2000-07-21 BR BR0012696-9A patent/BR0012696A/pt not_active Application Discontinuation
- 2000-07-21 HU HU0202243A patent/HU230738B1/hu unknown
- 2000-07-21 WO PCT/EP2000/007030 patent/WO2001007049A2/en not_active Application Discontinuation
- 2000-07-21 UA UA2002010531A patent/UA74788C2/uk unknown
- 2000-07-21 CZ CZ20020243A patent/CZ300614B6/cs not_active IP Right Cessation
- 2000-07-21 KR KR1020017015745A patent/KR20020012261A/ko not_active Application Discontinuation
- 2000-07-21 JP JP2001511933A patent/JP2003505419A/ja active Pending
- 2000-07-21 BR BRPI0017528A patent/BRPI0017528B8/pt not_active IP Right Cessation
- 2000-07-21 IL IL14697300A patent/IL146973A0/xx unknown
- 2000-07-21 EE EEP200200040A patent/EE05439B1/xx unknown
- 2000-07-21 CA CA002377024A patent/CA2377024A1/en not_active Abandoned
- 2000-07-21 CN CN00809538A patent/CN1358086A/zh active Pending
- 2000-07-21 PL PL352382A patent/PL202496B1/pl unknown
- 2000-07-21 NZ NZ516108A patent/NZ516108A/en not_active IP Right Cessation
- 2000-07-21 EP EP00953080A patent/EP1198223A2/en not_active Withdrawn
-
2002
- 2002-01-17 ZA ZA200200425A patent/ZA200200425B/en unknown
- 2002-01-21 NO NO20020319A patent/NO331228B1/no not_active IP Right Cessation
- 2002-04-29 US US10/134,795 patent/US6774137B2/en not_active Expired - Lifetime
- 2002-09-25 HK HK02107011.8A patent/HK1046631A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
HUP0202243A3 (en) | 2006-03-28 |
ZA200200425B (en) | 2002-10-30 |
BRPI0017528B1 (pt) | 2017-06-13 |
IL146973A0 (en) | 2002-08-14 |
PL352382A1 (en) | 2003-08-25 |
EP1198223A2 (en) | 2002-04-24 |
HUP0202243A2 (hu) | 2002-12-28 |
BRPI0017528B8 (pt) | 2021-05-25 |
US6777429B1 (en) | 2004-08-17 |
CZ2002243A3 (cs) | 2002-04-17 |
RU2248789C2 (ru) | 2005-03-27 |
PL202496B1 (pl) | 2009-06-30 |
NO20020319L (no) | 2002-01-21 |
EE05439B1 (et) | 2011-08-15 |
NO20020319D0 (no) | 2002-01-21 |
MXPA02000849A (es) | 2002-07-30 |
JP2003505419A (ja) | 2003-02-12 |
WO2001007049A3 (en) | 2001-03-29 |
CZ300614B6 (cs) | 2009-07-01 |
US6774137B2 (en) | 2004-08-10 |
KR20020012261A (ko) | 2002-02-15 |
CA2377024A1 (en) | 2001-02-01 |
UA74788C2 (en) | 2006-02-15 |
US20020183359A1 (en) | 2002-12-05 |
CN1358086A (zh) | 2002-07-10 |
WO2001007049A2 (en) | 2001-02-01 |
BRPI0017528A2 (pt) | 2010-01-19 |
HK1046631A1 (zh) | 2003-01-24 |
NO331228B1 (no) | 2011-11-07 |
NZ516108A (en) | 2004-04-30 |
EE200200040A (et) | 2003-04-15 |
HU230738B1 (hu) | 2018-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0012696A (pt) | Composição oftálmica | |
SE0001899D0 (sv) | New compounds | |
DK1697370T3 (da) | Azabicykliske heterocykliske forbindelser som cannabinoidreceptormodulatorer | |
BR0214343A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
AU2002225772A1 (en) | Therapeutic agents and methods of use thereof for treating an amyloidogenic disease | |
BR0307893A (pt) | Formulação oftálmica com sistema de goma | |
MXPA04004837A (es) | Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1. | |
BR9917007A (pt) | Moduladores de ccr5 | |
BR0012752A (pt) | Benzofuril piperazinas e benzofuril homopiperazinas: agonistas de serotonina | |
AR027391A1 (es) | Composiciones farmaceuticas de toxina botulinica | |
BRPI0417820A (pt) | heterociclos azabicìclicos como moduladores de receptor canabinóide | |
BR0001468A (pt) | ácidos dioxiciclopentil hidroxânicos | |
EA200901393A1 (ru) | Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат | |
AU3850600A (en) | Dalda analogs and their use | |
HUP0103781A2 (hu) | Megismerési képesség javítására szolgáló gyógyszerkészítmények, melyek atipikus antipszihotikus szer és acetilkolinészteráz inhibitor kombinációját tartalmazzák | |
BR0210013A (pt) | Gel oftálmico de pirenzepina | |
BR9916575A (pt) | Composição farmacêutica de liberação controlada com mesilato de tilidina como substância-ativa | |
SE0102055D0 (sv) | New Compounds | |
BR9914128A (pt) | Composições antibióticas para tratamento do olho, ouvido e nariz | |
RS44204A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
BR9910024A (pt) | Agente contra resfriado | |
NO20014240D0 (no) | C16-umettede FP-selektive prostaglandinanaloger | |
DE60128100D1 (de) | Analgetisches arzneimittel | |
PT1187611E (pt) | Composicoes oftalmicas de histamina e sua utilizacoes | |
BR9915123A (pt) | Composição de uma substância farmaceuticamente ativa e dispensador |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: ALTERADA DE INT.CL: A61K 31/445 Ipc: A61K 9/08 (2009.01), A61K 9/00 (2009.01), A61K 31/ |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8 E 13 DA LPI |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |